✦ LIBER ✦

A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma

✍ Scribed by William Bensinger; Richard T. Maziarz; Sundar Jagannath; Andrew Spencer; Simon Durrant; Pamela S. Becker; Brett Ewald; Sanela Bilic; John Rediske; Johan Baeck; Edward A. Stadtmauer

Book ID: 117946831
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 173 KB
Volume: 159
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2012.09251.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

372 A phase I dose-escalation study of t

372 A phase I dose-escalation study of the fully human monoclonal antibody MNRP1685A (anti-NRP1) administered intravenously to patients with advanced solid tumors

✍ C. Weekes; P. Hedge; Y. Xin; R. Yu; H. Xiang; L. Gore; M. Beeram; R. Brachmann; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

28 A First-in-human Phase I Study to Eva

28 A First-in-human Phase I Study to Evaluate the Fully Human Monoclonal Antibody OMP-59R5 (anti-Notch2/3) Administered Intravenously to Patients with Advanced Solid Tumors

✍ Smith, D.C.; Chugh, R.; Patnaik, A.; Papadopoulos, K.; Chambers, G.; Thorpe, V.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 75 KB

1227 A phase 1, dose-escalation study of

1227 A phase 1, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in patients with relapsed or refractory solid tumours

✍ M. von Mehren; C. Britten; P. Piesolor; K. Balogh; A. Bartok; S. Harris; X. Li; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

630 POSTER Results of a phase 2 study of

630 POSTER Results of a phase 2 study of HGS-ETR1, a fully human agonistic monoclonal antibody to TRAIL Receptor 1, in subjects with relapsed or refractory colorectal cancer (CRC)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB